Why does compounded tirzepatide come as a lyophilized powder?
Peptides like tirzepatide are chemically unstable in solution over long periods. Lyophilization — freeze-drying — removes water and converts the peptide to a stable powder that can be stored at room temperature or refrigerated without degradation for months. When you’re ready to use it, you reconstitute it into solution.
Compounded tirzepatide is not an FDA-approved drug. It is prepared by licensed 503A compounding pharmacies in the United States, patient-specific, and dispensed with a clinician prescription. It is not Mounjaro or Zepbound and is not manufactured by Eli Lilly. No hidden overseas supply chain.
What you need before reconstitution
- The tirzepatide vial from your licensed 503A pharmacy, labeled with the total milligrams of peptide inside.
- Bacteriostatic water for injection (BAW): This is sterile water with 0.9% benzyl alcohol as a preservative. Benzyl alcohol inhibits microbial growth, which is why reconstituted vials can be stored for weeks. Sterile water (without benzyl alcohol) is less suitable because a multi-use vial without a preservative degrades quickly and carries contamination risk.
- Two syringes: One to draw and inject the bacteriostatic water into the vial; one (or the same, depending on your protocol) for your dose.
- Alcohol swabs.
- Your clinician’s instructions specifying the target volume of BAW and your dose in units or milliliters. Do not reconstitute until you have these — guessing the dilution volume is the most common reconstitution error.
How do you calculate tirzepatide concentration after reconstitution?
The single most important concept in tirzepatide reconstitution is understanding the resulting concentration, because concentration determines what volume on your syringe equals your prescribed dose.
Concentration (mg/mL) = total mg in vial ÷ mL of bacteriostatic water added
Example: a vial containing 10 mg of lyophilized tirzepatide, reconstituted with 2 mL of bacteriostatic water, produces a concentration of 5 mg/mL. If your prescribed dose is 2.5 mg, you would draw 0.5 mL (or 50 units on a U-100 insulin syringe).
The same 10 mg vial reconstituted with 1 mL instead gives 10 mg/mL — and now 0.5 mL contains 5 mg, double the intended dose. This is why reconstitution volume is not a preference — it is a clinical instruction you must follow exactly.
In reconstitution, the diluent volume isn’t a preference — it sets the concentration that defines every dose you will ever draw.
Step-by-step reconstitution process
Your pharmacy and clinician will provide the definitive instructions for your specific preparation. The general process:
- Wash hands and work on a clean surface. This is a sterile injection — contamination risk starts here.
- Wipe the rubber stopper of the tirzepatide vial and the bacteriostatic water vial with alcohol swabs. Allow to air dry briefly.
- Draw the prescribed volume of BAW into the syringe. Use the volume specified in your instructions — this is the number that controls concentration.
- Inject BAW into the tirzepatide vial slowly, directing the liquid toward the wall of the vial rather than directly onto the powder cake. Do not shake — swirl gently.
- Allow to dissolve by gently swirling or rolling the vial until the solution is clear. This typically takes a few minutes. If the powder does not dissolve or the solution appears cloudy after gentle mixing, do not use it.
- Inspect the solution: it should be clear and colorless or very slightly yellow. Discard if particulate matter is visible.
- Label the vial with the date of reconstitution. Refrigerate immediately.
Storage after reconstitution
Reconstituted tirzepatide is stable refrigerated (2–8°C / 36–46°F) for the duration specified on your pharmacy label, typically 28 to 30 days. Follow the expiration on the label — compounding pharmacies set this date based on the specific preparation and USP sterile compounding standards.
- Do not freeze the reconstituted solution.
- Remove from refrigerator 15–30 minutes before injecting to bring to near room temperature; cold solution can be more uncomfortable.
- Discard if past the expiration date, if the solution is discolored, if particulate matter is visible, or if the vial was dropped and may have been contaminated.
Injection site and technique
Compounded tirzepatide is administered subcutaneously — into the layer of fat beneath the skin. Common injection sites:
- Abdomen: Two inches away from the navel. Most consistent absorption kinetics. Easiest for self-injection.
- Outer thigh: Front-outer quadrant. Good alternative if the abdomen is irritated.
- Upper arm (posterior): Requires assistance or a specific injection angle for self-administration.
Rotate injection sites to avoid lipodystrophy (fatty tissue changes at repeated injection sites). Wipe the site with an alcohol swab and allow to dry before injecting. Pinch the skin, insert at the angle your clinician instructs (typically 45–90 degrees depending on body composition), inject slowly, withdraw, apply gentle pressure.
Frequently asked questions
What does tirzepatide reconstitution mean?
Lyophilized (freeze-dried) tirzepatide powder must be dissolved in bacteriostatic water before injection. Reconstitution is the process of adding the correct volume of bacteriostatic water to the vial so the peptide dissolves into a stable, injectable solution at the intended concentration.
How do I calculate the tirzepatide reconstitution ratio?
Concentration (mg/mL) = total mg of peptide in the vial ÷ volume of bacteriostatic water added (in mL). Your clinician provides both the vial contents and the target concentration. Never guess the volume — the math determines how many units on your syringe equal your prescribed dose.
What syringe do I use for tirzepatide injections?
Most compounded tirzepatide programs use an insulin syringe (U-100, 1 mL) because the markings align with the small subcutaneous volumes involved. Your clinician specifies the syringe type and unit marking that corresponds to your prescribed dose.
How should reconstituted tirzepatide be stored?
Reconstituted tirzepatide should be stored in the refrigerator (2°C–8°C / 36°F–46°F). Do not freeze. Most compounded preparations are stable for 28–30 days refrigerated; check the expiration date your pharmacy provides and the instructions in your prescription package.
Is compounded tirzepatide the same as Mounjaro or Zepbound?
No. Compounded tirzepatide is not an FDA-approved drug. It is compounded in the USA by licensed 503A pharmacies and is not manufactured by Eli Lilly, the maker of Mounjaro and Zepbound. Compounded products are not bioequivalent-tested to branded products. Your clinician prescribes the appropriate preparation for your protocol.
What if I accidentally add too much bacteriostatic water?
Do not use the vial if you are uncertain about the concentration. An incorrect dilution means every dose you draw will be off. Contact your pharmacy or prescribing clinician before injecting.